This is a limited company view. Sign up for a Free Trial to see everything.

Cibiem, a medical device company, develops minimally invasive, catheter-based therapeutics for sympathetic nervous system-mediated diseases.

B2B
Biotechnology
Healthcare
Medical Devices
Pharmaceuticals

Overview

Location

New York

Founded

Employees

0

Stage

Series A

Total funding

$10M

Last funding

5 years ago

Acquisitions

0

Growth score

26

Mindshare score

26

Scoring

Deals

$10.0M Series A

SV Life Sciences, Third Rock Ventures

Oct 17, 2012

Employee Growth

Use Cibiem's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Cibiem's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Similar Companies

Alethia BioTherapeutics

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Series B

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes